Axicabtagene ciloleucel car+
Full descriptor
Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Details
- Code
- Q2041
- Short descriptor
- Axicabtagene ciloleucel car+
- Code set
- HCPCS Level II
- Release
- July 2026
- Status
- Active
- Added
- Apr 1 2018
Nearby codes
Code sets are published in blocks, so neighbours are usually related.
Tisagenlecleucel car-pos t
Influenza virus vaccine, nos
Sipuleucel-t auto cd54+
Fluzone vacc, 3 yrs & >, im
Fluvirin vacc, 3 yrs & >, im
Flulaval vacc, 3 yrs & >, im
Afluria vacc, 3 yrs & >, im
Agriflu vaccine
Sources
- CMS HCPCS Level II — July 2026, public domain
Reference information only. Not billing advice. Verify against the payer before you file.